RIL
DAWN

Rothschild Investment LLC’s Day One Biopharmaceuticals DAWN Stock Holding History

Rothschild Investment LLC’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-282
Closed -$6.05K – 3662
2026
Q1 		$6.05K Buy
282
+55
+24% +$775 ﹤0.01% 1956
2025
Q4 		$2.12K Buy
227
+2
+0.9% +$17 ﹤0.01% 2333
2025
Q3 		$1.59K Buy
225
+105
+88% +$722 ﹤0.01% 2377
2025
Q2 		$780 Buy
120
+25
+26% +$172 ﹤0.01% 2583
2025
Q1 		$753 Buy
95
+45
+90% +$485 ﹤0.01% 2486
2024
Q4 		$634 Sell
50
-15
-23% -$209 ﹤0.01% 2446
2024
Q3 		$905 Buy
65
+35
+117% +$499 ﹤0.01% 2238
2024
Q2 		$413 Buy
30
+20
+200% +$293 ﹤0.01% 2134
2024
Q1 		$165 Buy
+10
New +$150 ﹤0.01% 1843

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rothschild Investment LLC's DAWN Position: Q2 2026 in Review

Rothschild Investment LLC sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 282 shares — an estimated $6.05K sold.

Rothschild Investment LLC first reported a position in DAWN in Q1 2024 and held it in 9 quarters. The position peaked at $6.05K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Rothschild Investment LLC reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Rothschild Investment LLC sold 282 Day One Biopharmaceuticals shares in Q2 2026, an estimated $6.05K.
  • Rothschild Investment LLC first reported a position in Day One Biopharmaceuticals in Q1 2024 and held it in 9 quarters.
  • Rothschild Investment LLC's Day One Biopharmaceuticals position peaked at $6.05K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.